Shanghai VKEY Biotechnologies Co.,Ltd.
Shanghai VKEY Biotechnologies Co.,Ltd.
Email Us

Blog

05
Sep
New Product Launch | VKEY-BIO TR-FRET Effector Function Analysis Kits for Precise Evaluation of Antibody ADCC/ADCP Activity
Background Monoclonal antibodies (mAbs), as a class of precision-targeted immunoglobulins (Ig), consist of an antigen-binding region (F(ab')₂) and an effector function region (Fc). In terms of m...
04
Sep
New Product Launch | TL1A/DR3 & TL1A/DcR3 Binding Assay Kits, Pioneering Breakthroughs in Autoimmune Disease Drug Development
Introduction In the field of autoimmune disease treatment, TL1A (TNF-like ligand 1A) and its receptors DR3 (Death Receptor 3) and decoy receptor DcR3 (Decoy Receptor 3) have emerged as promising new ...
03
Sep
New Product Launch | FcRn Binding Assay Kit for Accurate Assessment of Antibody Half-Life & Screening of FcRn Inhibitors
In our previous issue, we introduced VKEY-BIO's new TR-FRET Effector Function Analysis Kits (CD16a/CD64) to aid in the assessment of antibody ADCC/ADCP functions. This issue focuses on another cor...
02
Sep
High-Throughput & Anti-Interference & Accurate Quantification ------ A New Hybridoma Screening Solution Combining Three Effects
The Challenges and Breakthroughs in Hybridoma ScreeningIn monoclonal antibody development, hybridoma screening is a critical bottleneck. Traditional methods (like ELISA) are time-consuming (often requ...
01
Sep
cAMP Detection 'Three Musketeers': Classic, Wide-Range, and Ultra-Wide Detection—There’s One for Every Need
Cyclic adenosine monophosphate (cAMP) is a crucial intracellular second messenger involved in regulating various physiological processes, such as metabolism, secretion, and gene expression. In drug de...